Theratechnologies organizacji PEG
Jaka jest wartość PEG organizacji Theratechnologies?
Wartość PEG organizacji Theratechnologies, Inc. to 740.91
Jaka jest definicja PEG?
Wskaźnik cena / zysk do wzrostu (PEG) to wskaźnik P / E dla akcji podzielony przez prognozowaną stopę wzrostu swoich zysków za okres 5 lat.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG firm w Health Care sektor na TSX w porównaniu do Theratechnologies
Czym się zajmuję organizacja Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Firmy z peg podobne do Theratechnologies
- Wartość PEG organizacji CenturyLink to 419.23
- Wartość PEG organizacji Tuniu Corp to 453.00
- Wartość PEG organizacji Western Digital to 490.33
- Wartość PEG organizacji Alexandria Real Estate Equities to 537.70
- Wartość PEG organizacji SFC AG to 556.47
- Wartość PEG organizacji Oxford Immunotec Global PLC to 588.67
- Wartość PEG organizacji Theratechnologies to 740.91
- Wartość PEG organizacji Hathway Cable and Datacom to 770.00
- Wartość PEG organizacji Upwork Inc to 793.75
- Wartość PEG organizacji Apartment Investment & Management Co to 839.32
- Wartość PEG organizacji Knight Therapeutics to 861.00
- Wartość PEG organizacji HealthCare Global Enterprises to 1,059.90
- Wartość PEG organizacji Shionogi & Co to 24,611.80